| O 基金经理 : 金晟哲 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 会晟哲 | 累计任职时间：8年又289天 任职起始日期：2016-10-24 现任基金公司：博时基金管理有限公司 现任基金资产 - 在管基金最佳 总规模 任期回报 49.16 乙元 88.78% | | 基金经理简介:金晟哲先生:中国国籍,硕士。2012年从北京大学硕士研究生毕业后加入博时基 金管理有限公司。历任研究员、高级研究员、资深研究员、博时睿利定增灵活配置混合型证 券投资基金(2017年2月28日-2017年12月1日)、博时睿益定增灵活配置混合型证券投资基金 (2017年2月28日-2018年2月22日)、博时睿益事件驱动灵活配置混合型证券投资基金(LOF) (2018年2月23日-2018年8月13日)、博时睿丰灵活配置定期开放混合型证券投资基金(2017年 3月22日-2018年12月8日)的基金经理、研究部副总经理、博时价值增长证券投资基金(2017年 11月13日-2021年7月12日)、博时睿利事件驱动灵活配置混合型证券投资基 ...

Core Viewpoint - The BoShi Healthcare Industry Mixed A Fund has experienced a decline of 0.92% on June 19, with a cumulative drop of 5.29% over the last five trading days, indicating a challenging market environment for the fund [1]. Group 1: Fund Performance - As of June 19, the latest net value of BoShi Healthcare Industry Mixed A is 2.36 yuan, marking a continuous decline over five trading days [1]. - The fund was established in August 2012, with a total fund size of 2.093 billion yuan and a cumulative return of 164.39% since inception [1]. Group 2: Investor Composition - By the end of 2024, institutional investors hold 0.02 million shares, accounting for 0.24% of the total shares, while individual investors hold 9.34 million shares, making up 99.76% of the total shares [1]. Group 3: Fund Management - The current fund manager, Ms. Chen Ximing, has been with BoShi Fund Management Company since 2016, serving in various roles including researcher and senior researcher [1]. - Ms. Chen has been managing the BoShi Healthcare Industry Mixed A Fund since March 14, 2023, and also manages the BoShi Health Growth Theme Biweekly Redeemable Mixed Securities Investment Fund [1]. Group 4: Top Holdings - As of March 31, 2025, the top ten holdings of BoShi Healthcare Industry Mixed A account for a total of 38.71%, with the largest positions in Zai Lab (7.09%), Kelun Pharmaceutical (5.41%), and Dabo Medical (4.79%) [2].